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Purpose: The study evaluated the deployment and healing of a novel self-expanding 
modular bifurcation endovascular prosthesis in a canine abdominal aortic aneurysm 
model. The endoluminal prosthesis consists of self-expanding nitinol stents lined by a 
synthetic prosthesis. One component of the device is a bifurcated body with a 12- to 
14-mm diameter aortic segment and an integral 7- to 8-mm diameter iliac limb. The 
bifurcated body also has a stent-reinforced opening (pant-leg) for subsequent insertion of 
a contralateral 7- to 8-mm diameter iliac limb component. 
Methods: Seventeen bifurcated prosthesis were placed; 7 were inserted through the left 
common carotid artery and 10 from the femoral rteries. With either oute of access the 
16F or 17F aortoiliac limb and the 13F iliac limb delivery catheters enabled easy passage 
and secure positioning of the bifurcated prostheses. Predeployment and postdeployment 
inspection of the dimensions and continuity of the aortoiliac prosthetic omponents were 
evaluated by cinefluoroscopy and intravascular ultrasonography (IVUS). 
Results: After deployment was done, interval patency was assessed with angiography, 
IV-US, and contrast-enhanced computed tomography with the prostheses removed for 
analysis at I week (n = 4), I month (n = 3), 3 months (n = 4), and 6 months (n = 6). Five 
of the first seven implanted prostheses had occlusion of segments of the device. In two 
dogs the bifurcated body and both legs were occluded. In the other three the nonoccluded 
leg and bifurcation body were fitlly patent. In the first seven animals IVUS at implantation 
showed compression ofan iliac leg by the orifice of the contralateral iliac component. After 
concentric fixation of the flow divider was performed, only one additional iliac limb 
occlusion occurred in the next 10 animals. Cinefluoroscopy, computed tomography, 
IVUS imaging, and histologic analysis of retrieved specimens demonstrated healing of the 
aortoiliac prostheses without evidence of perigraft leaks. 
Conclusions: This feasibility study demonstrates the ability to deploy and maintain 
acceptable patency of a self-expanding endoluminal, modular bifurcation prosthesis in a 
canine aortic model. Clinical evaluation of the device is planned for the near future. (J Vasc 
Surg 1996;24:1034-42.) 
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Endovascular prosthetic treatment of abdominal 
aortic aneurysms i being investigated in many cen- 
ters throughout the world with encouraging prelim- 
inary clinical results. The potential for accomplishing 
aneurysm exclusion with minimal intcrventional 
methods that offer shorter disability and recovery 
periods and the potential for shorter convalescent and 
hospitalization costs mal<e the concept very appeal- 
ing. 1-4 
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In clinical evaluations that have been conducted, 
only approximately 10% to 20% of patients with ab- 
dominal aortic aneurysms have been candidates for 
straight ubular endotuminal graft treatment. 4 One 
reason for the low eligibility rates is the lack of 
nonaneurysmal tissue at the bifurcation. Fixation of 
all ends of the prosthesis in nonaneurysmal tissue is 
required for adequate sealing. For this reason abifur- 
cated endovascular p osthesis that would increase the 
number of  eligible panents is desirable. At present, 
the most widely used endovascular method to treat 
complex abdominal aortic aneurysms that would oth- 
erwise require abifurcated prostheses i  accomplished 
by aneurysm exclusion with an endovascular aor- 
toiliac bypass, occlusion of the contralateral iliac ar- 
tery, and femorofemoral bypass to revascularize the 
lower extremities. 1,s,s,6 Several prototypes of  bifur- 
cated prostheses are also being evaluated in experi- 
mental animal and clinical procedures. 7-1° 
This study evaluates a self-expanding, modular 
endovascular p osthesis in a canine abdominal aortic 
aneurysm odel. The study represents he first report 
of long-term animal implantation of a bifurcated 
endovascular p osthesis in a canine aortic model and 
reviews the design characteristics required for suc- 
cessful device performance. 
METHODS 
Bifurcated endoluminal prosthesis. The study 
evaluated the deployment and healing of a self-ex- 
panding modular bifurcated endovascular p osthesis 
(AneuRx, Inc., Cupertino, Calif. ) in a canine abdom- 
inal aortic aneurysm model. The endoluminal pros- 
thesis consists of self-expanding itinol (nickel-titani- 
um alloy) stents lined by a Dacron prosthesis. One 
component of  the device is a bifurcated body with a 
12- to 14-mm diameter aortic segment and an inte- 
gral 74 to 8-mm diameter iliac limb. The bifurcated 
body also has a reinforced opening (pant-leg) for 
subsequent insertion of  a contralateral 7- to 8-mm 
diameter iliac limb component (Fig. 1 ). 
The nitinol stent grafts were radially compressed 
and loaded into the end of a delivery catheter. The 
aortoiliac omponents were oriented with the aortic 
end of the prosthesis behag closest o the tip of  the 
delivery catheter when retrograde femoral artery in- 
troduction was to be used. When antegrade carotid 
insemon was planned, the catheter was loaded with 
the iliac end of  the prosthesis at the tip of the catheter. 
The delivery catheters for the aortic components 
were 16F or 17F, and the iliac components were 13F. 
Implant procedure. Seventeen bifurcated de- 
vices were placed in 89 - 9.3 pound (range 80 to 114 
J 
Fig. 1. Component endovascular p osthesis composed of 
bifurcated body with integral iliac leg and separately in- 
serted contralateral iliac Component. 
pounds) canines; 7 were inserted through the left 
common carotid artery and 10 through the femoral 
arteries. Large canines were chosen to provide ade7 
quate sized aortoiliac vessels to accommodate the 
12 X 7 and 14 × 8 devices. Aortic diameters in these 
animals were 10.8 _+ 1.6 mm (range 9.1 to 14,8 
ram), and iliac diameters were 6.9 -+ 0.8 mm (range 
5.0 to 8.6 mm). Two 14 × 8 devices were implanted 
in dogs with i4.8-mm and 12.4-mm diameter aortas, 
and the 12 × 7 devices were placed in the remaining 
animals. Placing the endovascular p ostheses in aor, 
toiliac segments with these dimensions aCcommo- 
dated the recommendation for 10% oversizing to 
ensure firm fixation and yet avoided underexpansion 
of components in all but one iliac limb. 
The canine aneurysm odel has been previously 
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described and entails suturing an eUiptically shaped 
Dacron patch onto an infrarenal anterior aortot- 
omy. 11 After a 2- to 3-week healing and maturation 
period for the patch aneurysm, the endovascular 
prostheses were deployed to evaluate xclusion and 
healing characteristics ofthe devices. 
Retrograde prosthesis deployment. The en- 
doluminal deployment was begun by isolating both 
femoral arteries for retrograde prosthesis deployment 
or by isolating the left common carotid artery for 
antegrade introduction of the device. For retrograde 
introduction the femoral arteries were isolated, and a 
0.035-inch Gfidewire (Meditech, Inc., Natick, 
Mass.) was passed through the length of the aortoiliac 
segment. A 15 F outside diameter RAPID-TRAK 
hemostatic introducer sheath (AneuRx, Inc., Cuper- 
tino, Calif.) was passed over the guide wire to a 
position in the left iliac artery. The Glidewire was 
then replaced with an angiographic catheter, and an 
angiogram was obtained to identify the location of 
the renal arteries. Aortic bifurcation was calibrated to 
a ruler placed beneath the animal. A 0.25-inch Plati- 
nttm Plus guidewire (Meditech, Inc., Natick, Mass.) 
or comparable guide wire was inserted through the 
angiographic catheter, the catheter was removed, and 
a 6.2F 20 MHz intravascular ultrasound (IVUS) 
catheter was passed along the wire. As the IVUS 
catheter was introduced, the entire length of the 
aortoiliac segment and the aortic aneurysm was in- 
spected. The location of the renal arteries, the aortic 
bifurcation, and the deployment si e in the right iliac 
artery were identified by centering the cinefluoros- 
copy unit over the IVUS catheter so the images were 
in the center of the field, eliminating distortion re- 
lated to parallax. Dimensions of the segments were 
carefully measured. To complete the IVUS examina- 
tion the catheter was withdrawn from the level of the 
renal arteries through the right external iliac artery for 
three-dimensional reconstruction and to provide a 
continuous recording of the segment morphologic 
characteristics. 
After the IVUS data were acquired, the ultra- 
sound catheter was removed. A catheter exchange 
was performed to place a 0.038-inch Amplatz super- 
stiff wire (Meditech Inc., Natick, Mass.) for deploy- 
ment of the endoluminal device. With the landmarks 
identified by contrast cinefluoroscopy and IVUS, the 
delivery catheter was inserted until the radiopaque 
markings identifying the proximal aspect of the en- 
doluminal graft were placed at the infrarenal fixation 
site. The length of the deployment catheter was in- 
terrogated to ensure that the bifurcation and iliac 
limb were appropriately positioned. This procedure 
was accomplished by comparing the level of ra- 
diopaque markers on the endoluminal prostheses 
with the corresponding cinefluoroscopy images of 
the calibrated ruler beneath the field. With the pros- 
thesis in the correct position a special deployment 
handle was used to retract the outer graft cover of the 
delivery catheter, while the prosthesis remained inthe 
same anatomic location. As the prosthesis emerged 
from the delivery catheter and began to expand, its 
position was monitored to ensure full expansion at 
the desired location. The outer graft cover was then 
removed along the length of the endoluminal pros- 
theses until complete deployment of the device was 
apparent. This deployment was easily determined by 
watching the expansion of the radiopaque nitinol 
stent components a the sheath was retracted. 
After complete deployment of the graft was per- 
formed, the delivery device was removed, and an 
appropriately sized 10- to 14-mm internal diameter 
polyethylene Medi-Tech (PEMT) balloon angio- 
plasty catheter was passed over the Amplatz wire to 
the aortic segment of the device. Full expansion of 
the prosthesis graft material was ensured by inflating 
the balloon in a sequential manner from the proximal 
fixation site along the aortoiliac limb of the en- 
dograft. After the balloon was removed, an anglo- 
graphic atheter was exchanged for the Amplatz wire, 
and arteriography was performed to ensure full ex- 
pansion of the device and exclusion of the aneurysm. 
A 0.025-inch Platinum Plus wire was then intro- 
duced, the angiographic catheter was removed, and 
the IVUS catheter was reintroduced to interrogate 
the length of the endovascular p osthesis and the 
fixation sites. Dimensions of the fixation sites and any 
abnormal areas along the length of the device were 
inspected and measured. Redilation with a balloon 
catheter was performed as necessary. 
A 15F RAPID TRAK hemostatic sheath was then 
inserted into the left femoral artery. An Amplatz 
guide wire was passed through the left iliac pant leg, 
and the 7- or 8-mm diameter contralateral iliac limb 
of the endoluminal prosthesis was introduced. This 
component was positioned so that radiopaque mark- 
ers on the end of the graft were immediately beneath 
the bifurcated ivider. The sheath constraining the 
prosthesis was retracted, and the iliac segment was 
deployed. After deployment was performed, the de- 
livery catheter was removed, and an appropriate size 
PEMT balloon angioplasty catheter was introduced 
to ensure complete xpansion of the iliac limb. The 
angioplasty catheter was removed, an angiographic 
catheter was passed along the Amplatz wire, the wire 
was removed, and a 0.025 Platinum Plus wire was 
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inserted. The iliac limb and the entire length of the 
aortic interposition device were interrogated with 
IVUS. The IVUS was removed, and final angiogra- 
phy demonstrating adequacy of deployment and ex- 
clusion of the aneurysm was performed. The hemo- 
static sheaths were removed, the arteriotomies 
repaired, the wounds closed, and the procedure com- 
pleted. 
Antegrade prosthesis deployment. For ante- 
grade insertion of the prostheses the left common 
carotid artery was isolated and surrounded with 
Roummel tapes, and access was gained by inserting a
10F hemostatic sheath. A 0.025-inch angle Glidewire 
was passed through the carotid artery into the infra- 
renal aorta. A straight angiographic atheter was 
passed over the Glidewire, and the wire was removed. 
Infrarenal aortography was performed to identify the 
location of the renal arteries and the anatomy of the 
aortic bifurcation. A 0.025-inch Platinum Plus guide 
wire was passed through the lumen of the angio- 
graphi c catheter, and the catheter was removed. A 
6.2F, 20 MHz  intravascular ultrasound catheter was 
passed along the aortoiliac axis to determine the 
location of the renal arteries and aortic bifurcation 
referable to the cine images, to measure the dimen- 
sions of the corresponding arteries, and to measure 
the: length of the deployment site. The angiographic 
catheter was then replaced, and the 0.025-inch wire 
was removed. 
A 0.038:inch super stiffAmplatz wire was passed 
through the lumen of the angiographic catheter and 
into the left ifiac artery. The angiographic atheter 
was removed, and the 10F hemostatic sheath was 
replaced with a 19F outside diameter RAPID 
T~CK hemostatic ntroducer sheath: The endolu- 
mind prosthesis deployment was then conducted in 
the same sequence as the femoral approach discussed 
in the preceding section except hat the endoinminal 
prosthesis was loaded in the delivery catheter so that 
the :integral iliac limb was placed first, and as the 
sheath s~rronnding the self-expanding endoluminal 
prosthesis was removed, the aortic body of the device 
was deployed last. Appropriate infrarenal position 
was ensured by maintaining markers on the aortic 
limb in the appropriate location: Contralateral i!iac 
limb deployment was performed from the same ca- 
rotid access ite. 
~imats Used in this study were cared for in com- 
pliance ~h ~e Principles of Laboratory Animal 
Care (formu!ated bythe National Society for Medical 
Research) and the Guide for the Care and Use of 
Laboratory ~mals  (NIH Publication No. 86-23, 
revised i985). 
Postimplant surveillance. Animals were Idlled 
at 1 week, 1 month, 3 months, and 6 months to assess 
the interval pa~ency and to evaluate the healing of the 
devices. At the time ofdeath, the entire length ofthe 
aortoiliac segments was interrogated with contrast 
computed tomography scan, contrast cinefluoros- 
copy, and IVUS examinanon to evaluate prosthesis 
migration and perigraft leakage. 
After the devices were inspected with cinefluoros- 
copy and IVUS, the infrarenal segment was isolated 
and the segment perfusion fixed with formalin at 100 
mm mercury pressure. After fixation was performed, 
the gross specimens were photographed and then 
immersed in a saline solution. The internal surface of 
the endoluminal prosthesis was respected with an- 
gioscopy before sectioning the specimen. An anglo- 
scope was introduced through both iliac limbs of the 
specimen and the entire length of the reconstruction 
to examine the deployment of the device and the 
apposition of the prostheses ro surrounding tissues 
and to document any abnormalities. X-ray films of the 
specimens were also obtained to analyze the continu- 
ity of the deployed evice and the uniformity ofstent 
expansion. The specimens were then photographed 
and prepared for histologic analysis. 
The endoluminal graft prostheses were evaluated 
histologically by removing samples from the proximal 
interface, the middle of the prosthesis, the distal 
prosthesis/vessel interf~ice, and the proximal and dis- 
tal aorta 2 to 5 cm away from the prosthesis. All 
sections except the mid sections were oriented 
parallel to the long axis of the aorta. The mid- 
section specimen was a full-thickness transverse 
sccnon including native vessel, prosthesis, and lu- 
minal tissues. 
In addition, samples were taken for scanning elec- 
tron microscopy (SEM) and included full-thickness 
biopsy specimens of the aortic wall with the metal 
stent of the proximal and distal interfaces and in the 
middle of the prosthesis. Sections were placed in 
labeled vials of 10% formalin and were then postfixed 
in Karnofsky's fixative (a combination of paraffin 
formaldehyde and glutaraldehyde). The SEM analysis 
was performed on one animal from each death inter- 
val. Five to 6-~m thick paraffin-embedded s ctions of 
the aorta were stained with hematoxylin-eosin, Van 
Gieson stain, and Gomori's trichrome. 
Histologic examination i cluded the types of tis- 
sues infiltrating the prosthesis, the types of cellular 
infiltrate, evidence of arterial wall thinning or degen- 
eration, and the thickness and distribution of neoin- 
timal reactions in sections proximal to or overlying 
the device. 
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Fig. 2. Intravascular ultrasonography images of flow di- 
vider in bifurcated prostheses before (A) and after edesign 
of suprastructure (B) to ensure concentric positioning of 
iliac limbs without impingement or compression of one 
limb on the other. IVUS catheters (u) are positioned near 
flow divider within right iliac limb (single arrows) and 
obtain images of configuration of contralateral iliac limb 
(double arrows) across flow divider 0e). 
RESULTS 
After deployment was performed, interval pa- 
tency was assessed with contrast-enhanced omputed 
tomography. The prostheses were removed for anal- 
ysis at 1 week (n = 4), 1 month (n = 3), 3 months 
(n = 4), and 6 months (n = 6). Five of the first seven 
implantcd prostheses had occlusion of segments of 
the device. In two dogs the bifurcated body and 
both legs were occluded. In the other three the 
nonoccluded leg and bifurcated body were fully 
patent. In those animals, eccentricity of  the flow 
divider was seen on IVUS inspection at time of  
implantation but was not apparent on final cine- 
fluoroscopy examination of  the deployed prosthe- 
ses (Fig. 2). The animals with the eccentric flow 
dividers were monitored to determine the effect of  
the narrowing on patency and healing of  the limb. 
In addition, the device was modified to ensure a 
concentric smooth transition to both iliac limbs at 
the flow divider by shaping the suprastructure to
accommodate expansion of  the iliac limbs without 
impingement or  narrowing. After concentric fixa- 
tion of  the flow divider was performed, only one 
iliac limb in the last 10 prostheses deployed oc- 
cluded at 1 month. This occlusion occurred in an 
animal with 5-ram diameter iliac arteries that pre- 
vented complete xpansion of  the 7-ram iliac limb. 
Throughout  all of  the experiments the contralat- 
eral iliac limb was easily deployed with immediate 
sealing at the interface of  the modular prosthesis 
components. 
At removal, computed tomography scans, cine- 
fluoroscopy, and IVUS imaging of the aortoiliac seg- 
ments demonstrated full expansion and healing of all 
endovascular p ostheses without evidence ofperigraft 
leaks, fluid collections, or abnormalities in adjacent 
arterial segments. Fig. 3 demonstrates anangiogram 
of an abdominal aortic aneurysm before and at 6 
months after placement. Angioscopic examination of 
the lumen of the prostheses after emoval and forma- 
fin preservation were performed and demonstrated 
the degree of incorporation and luminal patency of 
the prostheses (Fig. 4). X-ray films of the specimens 
taken before histologic sectioning was performed 
confirmed maiform device expansion and luminal 
continuity (Fig. 5). 
Gross pathologic haracteristics. The AneuRx 
endovascular p osthesis appeared to be firmly seated 
in the aortas with no evidence of migration. The 
lumens of the endovascular p ostheses and the adja- 
cent aortic segments were isolated from the experi- 
mental aneurysms. Transition from the aortic body to 
the contralateral iliac limbs was smooth without lu- 
minal narrowing or evidence of leaks in patent spec- 
imens. Although variable quantities of organizing 
thrombus were found in the aneurysmal cavities, the 
lumens of the proximal and distal aortic segments and 
the grafts themselves were free of thrombus except 
for the previously described occluded prostheses. 
There was no evidence of aortic wall attenuation or 
JOURNAL OF VASCULAI~ SURGERY ~i~¢ et al. 1039 
Volume 24, Number 6 
Fig. 3. Representative angiogram of abdominal aorta after maturation of Dacron patch aneu- 
usm (A) and same animal 6 months after deployment of bifurca ed endovascular prosthesis (B). 
aneurysmal dilatation aside from the experimentally 
induced aneurysms. Aortic dissection or perforation 
was not present in any animal. 
Histolopathologic characteristics.* A variety 
ofhistologic changes were observed over time involv- 
ing both the endovascular p osthesis and the under- 
lying aortic wall. At 1 week after the procedure scat- 
tered neutrophils and fibrin deposition was seen 
within the Dacron mesh of the grafts and within the 
aortic intima. As healing progressed, the nature of the 
cellular component changed with loss of the neutro- 
phils and the appearance of occasional lymphocytes 
and macrophages including some multinucleated gi- 
*Histologic sample preparation and analyses were performed by 
CVD, Inc., West Sacramento, Calif. 
ant cells. These inflammatory infiltrates were minimal 
and are consistent with typical reactions to Dacron 
vascular prostheses. 
At 1 week histologic evidence offibroblast prolif- 
eration was observed. Fibroplasia was seen along the 
luminal aspects of the grafts and in the underlying 
aortas. The numbers of fibroblasts persisted and in- 
creased over time, and a gradual rise in the amount of 
deposited collagen was seen. Significant ingrowth of 
fibrous tissue occurred along and into the luminal 
borders of the Dacron mesh. Neointimal develop- 
ment also increased along the length of the prosthesis 
and was not isolated to the ends of the device. Small 
vascular channels were frequently observed within 
this fibrous tissue growth, providing evidence ofneo- 
vascularization. 
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Fig. 4. Angioscopy of luminal surface of bifurcated endo- 
vascular prosthesis een by cinefluoroscopy in Fig. 3. A, 
View of entire length of bifurcated body from infrarenal 
end of prosthesis (arrows) to bifurcation (b). B, View of 
aortic bifurcation and both iliac limbs. 
At 1 week and 1 month after implantation was 
performed, mild smooth-muscle c ll injury occurred 
in the aortic media. This injury was most often seen at 
or near the proximal graft-aorta interface but was also 
occasionally observed at other locations along the 
prostheses. Smooth-muscle cell degeneration was 
found in the inner one third of  the aortic media; this 
change was also occasionally seen in the middle and 
outer portions of  the media. At 3 and 6 months aortic 
smooth-muscle c ll injury was uncommonly found. 
At 1, 3, and 6 months the elastic fibers were attenu- 
ated, with disruptured areas being most prominent in 
the luminal one third of the media and less in the 
outer layers of  the aorta. 
Fig. 5. Representative x-ray film of excised aorta contain- 
ing &month bifurcated implant. P, Proximal aorta; a, 
Dacron patch aneurysm. 
Ingrowth of  fibrous tissue appears to have been 
the mechanism whereby the endovascular p ostheses 
became incorporated into the aorta. Fibrous thicken- 
ing of the underlying aorta was also noted. By 3 and 
6 months the entire outer length of the prosthesis was 
completely incorporated by a mature fibrous encap- 
sulation with a 200- to 400-mm neointimal lining of  
the luminal surface (Fig. 6). No evidence of  prosthe- 
sis migration after placement was found on gross or 
microscopic evaluation. No evidence of perforation 
of the aortic wall was seen. 
SEM. The SEM results were in accordance with 
the histologic changes in that fibrin predominated 
along the luminal surface at 1 week with replacement 
by fibrous tissue at the later intervals. Beyond 1 
month of implantation SEM showed patches and 
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Fig. 6. Representative Trichrome stain of specimen from mid section of 6-month implant from 
aortic wall. Opposite aneurysm demonstrating fibrous mcorporation fprosthesis with 200- to 
400-b~m neointimal lining of luminal surface (L). 
sometimes significant areas of neointimal formation 
not only at the proximal or distal ends of the endo- 
vascular graft but also in the mid-graft region. Occa- 
sionally vascular channels in the luminal surface were 
seen and accompanied the development of  intimal 
incorporation. 
D ISCUSSION 
The recent interest m the deployment of vascular 
prostheses with endoluminal delivery systems has 
identified new parameters that are required to accom- 
modate low-profile, catheter-based device design. 
The healing environment and factors affecting the 
bioincorporation of vascular prostheses are also dif- 
ferent from those encountered for grafts implanted 
with conventional surgical techniques. For these rea- 
sons new challenges regarding the biomechanical 
properties and healing characteristics of endoluminal 
prostheses must be addressed before widespread util- 
ity becomes areality. 
The need for developing low-profile delivery sys- 
tems for various applications uch as 16F to 22F 
devices for aortoiliac lesions and 9F to 14F sizes for 
smaller vessels has stimulated the use of thin-walled 
fabric and expandable polymers as the prosthetic 
material. The thin-walled fabrics must have adequate 
strength to provide integrity of the repair while pro- 
viding wall porosity that is compatible with immedi- 
ate hemostasis and rapid tissue incorporation. These 
requirements vary depending on the particular appli- 
cation for the device such as optimal hemostasis and 
tissue incorporation to exclude aneurysms from the 
vascular lumen. In some situations autogenous tissue 
grafts and collagen prostheses can be used to provide 
low-profile, nonthrombogenic grafts for smaller di- 
ameter vessels. 
The biomechanical characteristics of thin-walled, 
noncrimped grafts are different from those of conven- 
tional vascular prostheses. Commercially available 
grafts are crimped or wrapped with reinforcing mate- 
rials to resist kinking and compression of the vascular 
lumen. By eliminating the crimp and by thinning the 
wall to accomplish low-proNe delivery as an endovas- 
cular prosthesis~ the materials are easily deformed by 
pressure from adjacent structures, by motion, and by 
the intraluminal forces produced by pulsatile blood 
flow. 12 Each of these factors can cause narrowing and 
potentiate occlusion of the vascular lumen. For this 
reason several prototype ndoluminal prostheses are 
being developed with stent reinforcement along the 
entire length of the device. The bifurcated prosthesis 
evaluated in this study has stent reinforcement along 
the entire length of the prosthesis, which provides 
continued luminal expansion and column strength. 
The endoluminal prosthesis described in this arti- 
cle addresses several of the requirements for endolu- 
minal bifurcation devices. The modular design en- 
ables selection of component dhnensions to match 
the corresponding aortoiliac segments. Modular 
prosthesis design is also appearing in that individual 
components, particularly the iliac limbs, can be deliv- 
ered with lower profile catheters, thereby enlarging 
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the population of patients who will be candidates for 
treatment. Modular design also enables placement 
of additional segments to accommodate variable 
lengths. A disadvantage of the modular design is 
potential eaks at component interfaces, although 
none was encountered in this study. 
Devices were deployed by both antegrade (carot- 
id) and retrograde (femoral) routes to establish the 
feasibility for placement with both approaches. Al- 
though the femoral route is used most frequently for 
most endovascular devices, subclavian artery access 
may be a useful alternative in patients with contrain- 
dications to femoral placement such as extreme tor- 
tuosity or occlusive lesions in the iliac arteries. 
Previous tudies evaluating bifurcated endolumi- 
nal prosthetic devices in animal models have not 
addressed long-term healing. Chuter et al.7 studied 
the acute deployment of bifurcated grafts inserted 
into eight dogs but performed no chronic implanta- 
tions. The Endovascular Technologies bifurcated en- 
dovascular aortic prosthesis was also evaluated in an 
acute fashion in a calf model with attempts at long- 
term implantation limited by the death of three or 
four animals caused by spinal cord ischemia. 8 The 
longest implantation was 2 weeks and showed early 
wall repair without inflammatory cells and tissue 
growth across the anastomosis. The authors con- 
cluded that the calf animal model was not suitable for 
chronic graft evaluation of the bifurcated prosthesis 
because of the sensitivity for spinal cord ischemia. 
This study evaluates the AneuRx bifurcated en- 
doluminal vascular prosthesis n a canine model that 
was challenging because of small diameter and curva- 
ture of the vessels; the study demonstrated patency to 
6 months with uneventful healing and incorporation 
of the device in most of the animals. Efficacy of the 
device is accentuated by the fact that no anticoagula- 
tion was used during the postoperative period. 
Thrombosis of the iliac limbs related to eccentricity 
and compression of the lilac limbs and the nearly 
uniform patency of all devices after concentric fixa- 
tion of the flow divider highlight he sensitivity of the 
model for identifying flow-limiting lesions. The 
maintenance of long-term patency after redesign of 
the flow divider emphasizes the potential utility of 
this device. 
CONCLUSIONS 
This feasibility study demonstrates the ability to 
deploy and maintain acceptable patency of a self- 
expanding endoluminal, modular bifurcation pros- 
thesis in a challenging canine aortic model. Clinical 
evaluation of the prosthesis i  planned for the near 
future. 
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